Novavax (NVAX) Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate

Go back to Novavax (NVAX) Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate
Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.22 --0 (-0%)
Previous Close $10.22    52 Week High $9.23 
Open $10.22    52 Week Low $1.16 
Day High $10.22    P/E N/A 
Day Low $10.22    EPS $-0.30 
Volume 613